The descriptive presentation by the author almost makes one sit down and take a deep breath. However, I need to mow the rest of the yard before the arctic blast arrives tomorrow......in the meantime I can only wonder about events about to unfold and try not to count the chickens before they hatch.
The fda has never (that I am aware of) ok'd a cancer agent that is at least 10% effective. Imagine, an adjuvant cancer immunological treatment that produces minimal side effects and promotes a healthy immune response beyond any treatment available currently. Is it possible? How could the fda turndown a treatment producing a 30%, 50% or higher immune response that lasts far beyond any treatment currently available?
There is a guy named Gartman who is calling for drastic low prices in oil......if only we had a crystal ball. I will not pick up more till the dust settles.
it is just "the market", no if-ands or butts. Time and patience required if you think rexx will shine again someday.
you forgot to mention the removal of your nuts which is a common practice to reduce hormone excretion.
get real, do you buy a car without driving it first? The Clinique did not jump at the chance to be one of the first users of the focal1, they ran it thru it's paces and found it to be a very useful tool in their arsenal of weapons against prostate cancer. They bought it and now they are using it whenever the need is there. I say good for them, at least they had the option of saying yes or no, not like here in the U.S.
The Clinique urologique Nantes-Atlantis : A new expert center focal therapies
On, 26, 27 and 28 February the Nantes Atlantis Urology Clinic will host the 1st Nantes area day on “high intensity focused ultrasound therapy” for the treatment of prostate cancer using the Focal One equipment(EDAP TMS).
Focal One is the latest innovative high intensity focused ultrasound (HIFU) device with robotic assistance for use in the targeted treatment of prostate cancer. The Nantes Atlantis Urology Clinic is the second centre in France and the first private centre to use this treatment procedure.
Focal One, developed by the Lyon-based company EDAP TMS, is the first device to combine the advantages of MRI imaging in locating prostate tumours, 3D ultrasound and high intensity focused ultrasound for the treatment of some prostate cancers.
A therapeutic revolution for patients.
Interesting presentation by the Clinique, notice the dates (first paragraph) been in the works and it works fine.
Are you harping on the context of the post? Or the question I posed? Maybe it is the Bias thru treatment=inaccurate results?
that you do not grasp. I simply asked for a clarification of data posted by E75 (he/she is kind enough to post significant info regarding the clinical trial which I truly appreciate).
so the impact on interim date will be determined by the therapy received by patient before receiving E75? Bias thru treatment= inaccurate results? Neuvax may hit the mark but be blackeyed by under controlled chemo treatment.
that is not kosher for me.
You have to play the hand that's dealt, a year from now a new hand and a higher jackpot. I'm holding not folding.
You make a lot of sense. No excision, no bleeding, minimal anesthesia, no knock out for the surgery, minimal recovery time, positive results as provided by mri, reduced cost, etc. Naw... too easy, nobody will go for that.